• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

News & Events

  • Print
  • Share
  • E-mail

Public Calendar: October 24-28, 2011

This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the Federal Government.

October 24-28, 2011
FDA Official and TitleDateLocationOther FDA ParticipantsNon-FDA ParticipantsSubject
Margaret A. Hamburg, M.D., Commissioner of Food and Drugs10/22/11-10/27/11Sydney, AustraliaN/AN/A6th Annual Heads of Agencies Summit
John M. Taylor, III, J.D., Counselor to the Commissioner10/28/11Silver Spring, MD Deborah AutorLaurie Garrett (CFR)Globalization
Deborah M. Autor, Esq., Deputy Commissioner for Global Regulatory Operations and Policy10/24/11-10/28/11N/A N/AN/ANo Significant Meetings
Dara A. Corrigan, Associate Commissioner for Regulatory Affairs10/24/11-10/28/11N/A N/AN/ANo Significant Meetings
Virginia Cox, Associate Commissioner for External Affairs10/24/11-10/28/11N/AN/AN/ANo Significant Meetings
Lawrence Deyton, M.S.P.H., M.D., Director, Center for Tobacco Products10/24/11-10/28/11N/AN/AN/ANo Significant Meetings
Elizabeth H. Dickinson, Esq., Acting Chief Counsel10/24/11-10/28/11N/AN/AN/ANo Significant Meetings
David Dorsey, J.D., Acting Associate Commissioner for Policy and Planning10/24/11-10/28/11N/AN/AN/ANo Significant Meetings
Bernadette Dunham, D.V.M., Ph.D., Director, Center for Veterinary Medicine10/25/11Washington, DCN/AMembers of the Public Policy Committee and Executive Committee of the American Society of Animal ScienceGeneral Center for Veterinary Medicine Overview
Jesse Goodman, M.D., M.P.H., Chief Scientist and Deputy Commissioner for Science and Public Health10/25/11Washington, DCWilliam MaiselMembers of government, academia, and private industryAdvaMed Chief Technology and Science Officers Meeting regarding FDA Science Board, and other science-related activities at FDA
Jesse Goodman, M.D., M.P.H., Chief Scientist and Deputy Commissioner for Science and Public Health10/27/11Washington, DCN/ASeveral representatives from WHO, UNICEF, the Bill & Melinda Gates Foundation, NIAID and global health expertsPATH and DoV Collaboration regarding the development of the DoV Global Vaccine Action Plan
Michael M. Landa, Acting Director, Center for Food Safety and Applied Nutrition10/24/11-10/28/11N/AN/AN/ANo Significant Meetings
Caroline Lewis, Associate Commissioner for Operations10/24/11-10/28/11N/AN/AN/ANo Significant Meetings
Karen Midthun, M.D., Director, Center for Biologics Evaluation and Research10/24/11-10/28/11N/AN/AN/ANo Significant Meetings
Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health10/26/11Silver Spring, MDAshley Boam, Hina M Pinto, Bram ZuckermanTim Moran (PediaWorks); Thomas Forbes (Children's Hospital of Michigan)Bioresorbable Stent Project
Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health10/27/11Silver Spring, MDN/ASeveral representatives from MedTech Venture CapitalMedical Devices
William Slikker, Jr., Ph.D., Director, National Center for Toxicological Research10/28/11New Orleans, LAN/AN/AKeynote address at the Joint Regional Meeting of the South Central & Gulf Coast Chapters of the Society of Toxicology
Stephen Spielberg, M.D., Ph.D., Deputy Commissioner for Medical Products & Tobacco10/26/11Washington, DCN/AMembersSpeech at Alliance for a Stronger FDA Meeting
Stephen Spielberg, M.D., Ph.D., Deputy Commissioner for Medical Products & Tobacco10/26/11-10/27/11New York, NYN/ABoard MembersFoundation for the National Institutes of Health Board of Directors Meeting
Michael R. Taylor, J.D., Deputy Commissioner for Foods, Office of Foods10/28/11Silver Spring, MDN/ACaroline Smith DeWaal (Center for Science in the Public Interest)Food Safety
Michael R. Taylor, J.D., Deputy Commissioner for Foods, Office of Foods10/28/11Washington, DCSharon Natanblut

Tony Corbo, Wenonah Hauter, Patty Lovera (Food and Water Watch)

Food Safety
Jill Hartzler Warner, J.D., Acting Associate Commissioner for Special Medical Programs10/24/11-10/28/11N/AN/AN/ANo Significant Meetings
Janet Woodcock, M.D., Director, Center for Drug Evaluation and Research10/25/11Bethesda, MDSue-Jane Wang, Norman Stockbridge, Douglas Throckmorton, Elizabeth Mansfield, Robert O'NeilFrank Lichtenberg (Columbia University); Stephen Ruberg (Eli Lilly and Company); Jeremy Taylor (University of Michigan)Engelberg Center for Health Care Reform at Brookings:  Understanding and Discussing the Implications of FDA's Sentinel Initiative
Janet Woodcock, M.D., Director, Center for Drug Evaluation and Research10/25/11Washington, DCMelissa Robb, Rachel ShermanGarry Neil (Johnson & Johnson); Elliott Levy (Bristol-Myers Squibb); Briggs Morrison (Pfizer Inc.); Mark McClellan (Engelberg Center for Health Care Reform at Brookings); Richard Platt (Harvard Medical School and Harvard Pilgrim Health Care Institute)Engelberg Center for Health Care Reform at Brookings:  Understanding and Discussing the Implications of FDA's Sentinel Initiative
Janet Woodcock, M.D., Director, Center for Drug Evaluation and Research10/26/11New York, NYN/ABrenda Curiel (Center for Corporate Innovation, Inc.); Bill Bornstein (Emory Healthcare, Inc.); Pauk Chew (Sanofi-Aventis); John Orloff (Novartis Pharma AG); Marilyn Tavenner (The Centers for Medicare and Medicaid Services)East Coast Chief Medical Officer Executive Summit
Janet Woodcock, M.D., Director, Center for Drug Evaluation and Research10/27/11Boston, MAN/AJeffrey Flier (Harvard Medical School); Sameer Sabir (MoMelan Technologies); Robert Forrester (Verastem, Inc.); Peter Slavin (Massachusetts General Hospital)World Health Forum